ArticleDermatology and therapy2025

Long-Term Safety of Ixekizumab Treatment in Patients with Psoriasis, Psoriatic Arthritis, or Axial Spondyloarthritis: a Post Hoc Analysis of Cerebro-Cardiovascular Events.

Mark Lebwohl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.